The Case for Embracing the FDA’s Endorsed Data Standards

Publish Date:
March 9, 2017
Authors:
David C. Izard, Senior Director, Clinical Data Standards & Terek J. Peterson, MBA, Senior Director, Global Statistical Standards

In this white paper, we’ll discuss the guidances compelling organizations to compile data into standardized, digital datasets, the FDA’s motivation behind these changes and the benefits to — as well as the hopes of — the organizations that must submit standardized data.

There is also a related podcast on this topic, which you can download here.

TO DOWNLOAD THE White Paper SUBMIT THE INFORMATION BELOW
Fields marked with an * are required